Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Conditions that prevent use include a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, a history of severe pancreatitis, pregnancy, and active gallbladder disease
Methods Eligibility criteria The PICOS strategy was defined as follows: P (participants) human subjects, I (interventions) oral LC treatment, C (comparisons) between supplementation and placebo, supplementation and control, or pre- and post- supplementation, O (outcomes) muscle variables, and S (study design) randomized controlled trials, non-randomized controlled trials, non-randomized non-controlled trials
Never stop hormonal endometriosis treatment without medical guidance
Czechia Purity greater than 99.8 % confirmed by COA Assay content verified at 9.99 mg Molecular ion mass identified at 1646 Da Endotoxin level measured at 0.002 EU/mg No detectable heavy metals or microbial contamination Melanotan I peptide research compound For research use only not for human or veterinary use For laboratory research only
US$ 23.89
US$ 22.85
US$ 27.05
US$ 22.07
US$ 23.21
